Skip to news
JQJO
Latest

COVID mRNA Vaccines Boost Cancer Immunotherapy Survival | JQJO

COVID mRNA Vaccines Boost Cancer Immunotherapy Survival

COVID mRNA Vaccines Boost Cancer Immunotherapy Survival

Tap title to read story

0:00 / 0:42

A new Nature study reports that COVID-19 mRNA vaccines may boost cancer immunotherapy. Reviewing outcomes for more than 1,000 late-stage melanoma and lung cancer patients on immune checkpoint inhibitors, those vaccinated with Pfizer or Moderna within 100 days were over twice as likely to be alive at three years; patients whose tumors rarely respond saw nearly fivefold gains. Animal experiments suggest the vaccines act as an immune alarm, turning “cold” tumors “hot.” Researchers will launch a nationwide trial in lung cancer to test adding the vaccine to standard immunotherapy.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Cyber Expert Warns of U.S

Tap title to read story

0:00 / 0:50

US Wins Haiti, Pochettino Departs

Tap title to read story

0:00 / 0:37

Putin Criticizes EU at APEC Summit

Tap title to read story

0:00 / 0:44

MLB Lockout Threatens 2027 Season

Tap title to read story

0:00 / 0:35

Bedard Injured, Blackhawks Win 6-3

Tap title to read story

0:00 / 0:37

JQJO

Find your next story

Search JQJO’s current coverage.